Skip to content

A prospective, parallel group, interventional and open label study to evaluate the effect of probiotics on glycemic control in prediabetic patients

A prospective, parallel group, interventional and open label study to evaluate the effect of probiotics on glycemic control in prediabetic patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087286
Enrollment
70
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

Intervention1: Probiotic: One Probiotic capsule OD with 2.5 billion CFU containing four probiotics strains Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium longum and Saccharomyces

Sponsors

Governemnt Medical College Amritsar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Prediabetic patients visiting the Medicine Out Patient Department. 2. Both male and female patients of age more than 18 years. 3. Patients willing to join the study after giving the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patient not willing to provide a written consent for the study. 2. Patients who are currently on any lipid lowering agents. 3. Pregnant and lactating females. 4. Seriously and chronically ill patients. 5. Conditions of Inflammatory Bowel Disease and malabsorption.

Design outcomes

Primary

MeasureTime frame
Primary objective is to compare the levels of Fasting Plasma Glucose (FPG), Post Prandial Plasma Glucose (2h PG) and HbA1c in prediabetic patients on probiotic along with dietary control versus those on dietary control only.Timepoint: Day 0 Day 42 Day 90

Secondary

MeasureTime frame
Secondary objective is to assess the effect of probiotic on Body Weight, BMI, Total serum cholesterol, LDL cholesterol, HDL cholesterol, & Triglycerides of prediabetic patients with dyslipidemia recruited in the study.Timepoint: Day 0 Day 42 Day 90

Countries

India

Contacts

Public ContactAnjalika Brar

Government Medical College Amritsar

navyug69@gmail.com9878634358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026